Ablation of interferon regulatory factor 4 in T cells induces “memory” of transplant tolerance that is irreversible by immune checkpoint blockade
Open Access
- 23 November 2018
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (3) , 884-893
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01AI132492)
This publication has 30 references indexed in Scilit:
- CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapyJCI Insight, 2018
- Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell DysfunctionImmunity, 2017
- Chromatin states define tumour-specific T cell dysfunction and reprogrammingNature, 2017
- Transplantation tolerance after allograft rejectionCurrent Opinion in Organ Transplantation, 2017
- Erosion of Transplantation Tolerance After InfectionAmerican Journal of Transplantation, 2016
- Tumor Regression and Allograft Rejection after Administration of Anti–PD-1New England Journal of Medicine, 2016
- Repeated Injections of IL-2 Break Renal Allograft Tolerance Induced via Mixed Hematopoietic Chimerism in MonkeysAmerican Journal of Transplantation, 2015
- Murine Skin TransplantationJournal of Visualized Experiments, 2008
- Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockadeNature Medicine, 2003
- Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory BlockadeJournal of Experimental Medicine, 2001